274 related articles for article (PubMed ID: 32524950)
1. Estimating the Proportion of
Commons RJ; Simpson JA; Watson J; White NJ; Price RN
Am J Trop Med Hyg; 2020 Sep; 103(3):1094-1099. PubMed ID: 32524950
[No Abstract] [Full Text] [Related]
2. Management of relapsing Plasmodium vivax malaria.
Chu CS; White NJ
Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
[TBL] [Abstract][Full Text] [Related]
3. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
4. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
5. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.
Commons RJ; Rajasekhar M; Edler P; Abreha T; Awab GR; Baird JK; Barber BE; Chu CS; Cui L; Daher A; Gonzalez-Ceron L; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Lidia K; Llanos-Cuentas A; Longley RJ; Pereira DB; Pasaribu AP; Pukrittayakamee S; Rijal KR; Sutanto I; Taylor WRJ; Thanh PV; Thriemer K; Vieira JLF; Watson JA; Zuluaga-Idarraga LM; White NJ; Guerin PJ; Simpson JA; Price RN;
Lancet Infect Dis; 2024 Feb; 24(2):172-183. PubMed ID: 37748496
[TBL] [Abstract][Full Text] [Related]
6. Imported tertian malaria resistant to primaquine.
Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
[TBL] [Abstract][Full Text] [Related]
7. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
[TBL] [Abstract][Full Text] [Related]
8. Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia.
Zuluaga-Idárraga L; Blair S; Akinyi Okoth S; Udhayakumar V; Marcet PL; Escalante AA; Alexander N; Rojas C
Antimicrob Agents Chemother; 2016 Aug; 60(8):4610-9. PubMed ID: 27185794
[TBL] [Abstract][Full Text] [Related]
9. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
[TBL] [Abstract][Full Text] [Related]
10. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
11. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
13. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
Taylor AR; Watson JA; Chu CS; Puaprasert K; Duanguppama J; Day NPJ; Nosten F; Neafsey DE; Buckee CO; Imwong M; White NJ
Nat Commun; 2019 Dec; 10(1):5595. PubMed ID: 31811128
[TBL] [Abstract][Full Text] [Related]
14. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
15. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
[TBL] [Abstract][Full Text] [Related]
16. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
[TBL] [Abstract][Full Text] [Related]
17. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
[TBL] [Abstract][Full Text] [Related]
19. The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
Phommasone K; van Leth F; Imwong M; Henriques G; Pongvongsa T; Adhikari B; Peto TJ; Promnarate C; Dhorda M; Sirithiranont P; Mukaka M; Peerawaranun P; Day NPJ; Cobelens F; Dondorp AM; Newton PN; White NJ; von Seidlein L; Mayxay M
Malar J; 2020 Jan; 19(1):4. PubMed ID: 31900172
[TBL] [Abstract][Full Text] [Related]
20. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
